Skip to content

Income Tax at other companies

Amgen logo
AmgenAMGN
$265M+9.1%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$104M+8.0%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$9K+104%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$1.55M+921%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's income tax?
Replimune Group (REPL) reported income tax of -$311K in Q4 2025.
How has Replimune Group's income tax changed year-over-year?
Replimune Group's income tax decreased by 154.1% year-over-year, from $575K to -$311K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.